Table 3.
Possible strategies for de-escalation in BSIs.
Pathogen | Antimicrobial options |
---|---|
MSSA or MSSE | Oxacillin (12-16 g every 24 h c.i.) or cefazolin (2-4 g every 8 h c.i) |
Streptococci | Ampicillin (2 g every 4 h c.i.) or ceftriaxone (2 g every 24 h) |
Enterococcus faecalis | Ampicillin (2 g every 4 h c.i.) |
Non-ESBL Enterobacteriacae | Ceftriaxone (2 g every 24 h) |
ESBL-Enterobacteriacae | Ertapenem (500 mg every 6 h, e.i. 4 h) ) |
Susceptible P.aeruginosa | Piperacillin-tazobactam (4.5 g loading dose, then 18g q 24h c.i.) or antipseudomonal cephalosporin (ceftazidime 6 g every 24 h, c.i.or cefepime 6 g every 24 hours, c.i.) |
Fluconazole-susceptible Candida spp | Fluconazole (loading dose 12 mg/kg every 12 h, then 400 mg every 24 h) |
Notes. MSSA: methicillin-susceptible Staphylococcus aureus
MSSE: methicillin-susceptible Staphylococcus epidermidis